SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gene therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mike head who wrote (23)2/23/1999 10:22:00 PM
From: Mike McFarland  Read Replies (1) of 319
 
Hold and wait is my best suggestion.
Curagen is one that has plenty of cash,
and they seem a little tight lipped,
which could be a good sign. The quarterly
had all the events of the last year checked
off...but not a lot of talk about the future.
That's good, they don't seem too anxious to
talk the stock up. I would not be surprised
if insiders buy through the spring.

But if all that comes out of this endeavor
is that I accumulate a little knowledge of
genomics, well that is fine too.

Cant say I know anything about TKTX, I put
it on one of my watch lists, but I probably
wont get a chance to look into it...and it
doesn't scream super bargain like the other
things I have.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News